Sort
146,196 grants matching “diabetes”
Animal Models of Diabetic Vascular Disease
$934,670Rockefeller University · U01 · FY2005 · HL
Minimally invasive access and aspiration of circulating lymphocytes from the thoracic duct
$934,644Matthew Callaghan · Lymphaxis, Inc. · SB1 · FY2024 · DK
Genome-wide association study of coronary artery diseases in individuals of African ancestry
$934,617Yingchang Lu · Vanderbilt University Medical Center · R56 · FY2020 · HL
Neonatal Porcine Islet Xenografts for the Treatment of Type 1 Diabetes
$934,584Allan D. Kirk · Emory University · U01 · FY2012 · AI
A New Anti-inflammatory Therapy for Ischemic Stroke
$934,548Bruce Liang · Cornovus Pharmaceuticals, Inc. · R42 · FY2024 · HL
Fibrotic Sequelae of Childhood Renal Diseasae
$934,500Agnes B Fogo · Vanderbilt University · P50 · FY2010 · DK
Fibrotic Sequelae of Childhood Renal Diseasae
$934,500Agnes B Fogo · Vanderbilt University · P50 · FY2009 · DK
Fibrotic Sequelae of Childhood Renal Diseasae
$934,500Agnes B Fogo · Vanderbilt University · P50 · FY2008 · DK
Fibrotic Sequelae of Childhood Renal Diseasae
$934,500Agnes B Fogo · Vanderbilt University · P50 · FY2011 · DK
Studies of Rare Cancers
$934,284Louise Brinton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
Biosynthesis, Processing And Secretion of Neuropeptides And Pituitary Hormones
$934,224Yoke P Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
The New England Family Study: Fifty Year Post-Perinatal Follow-Up for Life Course
$934,139Eric Loucks · Brown University · RC2 · FY2010 · AG
Comprehensive CVD Risk Reduction Trial in Persons with Serious Mental Illness
$934,036Gail L Daumit · Johns Hopkins University · R01 · FY2017 · HL
Roles of RNA-binding Proteins in Programming Gene Expression in Mammals
$933,925Stefan Muljo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease
$933,572Jack A. Syage · Immunogenics, Llc · R44 · FY2021 · DK
Transformational next generation high affinity trispecific fab protein to address unmet needs in Ophthalmology
$933,533Li Xu · Revopsis Therapeutics, Inc. · R44 · FY2025 · EY
Transformational next generation high affinity trispecific fab protein to address unmet needs in Ophthalmology
$933,533Li Xu · Revopsis Therapeutics, Inc. · R44 · FY2024 · EY
Core B - Sequencing, Genotyping and Automated Mapping
$933,401Bruce A Beutler · Ut Southwestern Medical Center · P01 · FY2024 · AI
Core B - Sequencing, Genotyping and Automated Mapping
$933,400Bruce A Beutler · Ut Southwestern Medical Center · P01 · FY2025 · AI
Core B - Sequencing, Genotyping and Automated Mapping
$933,400Bruce A Beutler · Ut Southwestern Medical Center · P01 · FY2023 · AI
Comprehensive functional characterization and dissection of noncoding regulatory elements and human genetic variation
$933,353Pardis Christine Sabeti · Broad Institute, Inc. · UM1 · FY2018 · HG
Partnership for Primary Care Imaging
$933,337Stephen A Boppart · University Of Illinois At Urbana-Champaign · R01 · FY2014 · EB
Effects of Abscisic Acid on Insulin Sensitivity
$933,303Raquel Hontecillas · Biotherapeutics, Inc. · R44 · FY2020 · DK
NOVEL ASSAY TO DETECT CHRONIC KIDNEY DISEASE
$933,270Stephen L Carrithers · Sequela · R44 · FY2017 · DK
Mechanisms of Cell Regulation and Manipulation by the Ubiquitin System
$933,136Mark Hochstrasser · Yale University · R35 · FY2024 · GM